RNA Advisors supports investors and acquirers that are exploring investment opportunities in the life sciences and healthcare industries. We have supported buy-side clients involved in M&A ranging in size from pension plans to Venture Capital and Private Equity funds, to family offices and investors with an industry sub-sector focus (biotechnology, diagnostics, medical devices, digital health, etc.). Our team’s deep experience and our extensive research and financial analysis capabilities give us unique and relevant insights which we leverage for better client investment decisionmaking and transaction support.